Results 101 to 110 of about 118,577,238 (222)

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017

Emerging Microbes and Infections, 2018
The 2017 Hong Kong influenza A(H3N2) summer season was unexpectedly severe. However, antigenic characterization of the 2017 circulating A(H3N2) viruses using ferret antisera did not show significant antigenic drift.
Houshun Zhu, Andrew C. Y. Lee, Can Li, Winger W. N. Mak, Yetta Y. Chen, Kwok-Hung Chan, Anna J. X. Zhang, Wai-Fong Fung, Rui-Qi Zhang, Yim-Fong Fung, Rosana W. S. Poon, Joy-Yan Lam, Sidney Tam, Ivan F. N. Hung, Honglin Chen, Kwok-Yung Yuen, Kelvin K. W. To   +16 more
doaj   +1 more source

Reassortant H3N2 viruses used in this study.

, 2020
Reassortant H3N2 viruses used in this study.
Eun-Ji Choi (3638239), Yeon-Jung Kim (2818129), Byeongwoo Ahn (8275419), Kisoon Kim (427866), Young Jae Lee (411932), Jang-Hoon Choi (8275416), Jin-Moo Lee (232761), Myung Guk Han (8275422)   +7 more
core   +1 more source

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo

, 2013
Dongxi Xiang,1 Yang Zheng,2 Wei Duan,1 Xiujing Li,3 Jianjian Yin,3 Sarah Shigdar,1 Michael Liam O’Connor,1 Manju Marappan,1 Xiaojuan Zhao,4 Yingqiu Miao,3 Bin Xiang,5 Conglong Zheng31School of Medicine, Deakin University, Waurn Ponds, Victoria ...
Xiang B, Zheng CL, Xiang DX, Zheng Y, Marappan M, Zhao XJ, O'Connor ML, Miao YQ, Li XJ, Yin JJ, Duan W, Shigdar S   +11 more
core  

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach

, 2014
Dimitris Petridis,1 Paul Zarogoulidis,2,3 Anastasios Kallianos,4 Ioannis Kioumis,2 Georgia Trakada,5 Dionysios Spyratos,2 Antonis Papaiwannou,2 Konstantinos Porpodis,2 Haidong Huang,6 Aggeliki Rapti,4 Wolfgang Hohenforst-Schmidt,7 Konstantinos ...
Spyratos D, Rapti A, Zarogoulidis K, Huang H, Kioumis I, Hohenforst-Schmidt W, Papaiwannou A, Porpodis K, Petridis D, Kallianos A, Zarogoulidis P, Trakada G   +11 more
core  

Influenza A (H3N2) strain replacement during season 2014-2015 in the US.

, 2018
The number of influenza A (H3N2) viruses tested that are similar to the H3N2 vaccine strain (A/Texas/50/2012) are shown in grey, and the number of cases caused by viruses with reduced titers to antiserum raised against the vaccine strain is shown in red.
Veronika I. Zarnitsyna (381901), Ira M. Longini (669492), M. Elizabeth Halloran (125959), Irina Bulusheva (5451695), Andreas Handel (82914), Rustom Antia (29429)   +5 more
core   +1 more source

Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002

Journal of Virology
Subtype H3N2 influenza A viruses (IAVs), which emerged in 1968 to cause a pandemic, have shown continual circulation and adaptation that has necessitated frequent updates of candidate vaccine viruses.
Hui Lei, Biying Xiao, Xia Lin, Zaolan Liang, Shiman Ling, Yaqin Bai, Vijaykrishna Dhanasekaran, Wenjun Song, Sook-San Wong, Mark Zanin   +9 more
doaj   +1 more source

Emergence and Fixing of Antiviral Resistance in Influenza A Via Recombination and Hitch Hiking [PDF]

, 2009
The dramatic rise of oseltamivir resistance in the H1N1 serotype in the 2007/2008 season and the fixing of H274Y in the 2008/2009 season has raised concerns regarding individuals at risk for seasonal influenza, as well as development of similar ...
Henry L. Niman
core  

Effects of clodronate treatment on DK119-mediated protection against H3N2 influenza virus infection.

, 2013
Groups of mice (n = 6) were two times treated with DK119 (108 CFU/mouse) at 4 and 1 day earlier, then either received clodronate or PBS 4 hours prior to infection with A/Philippines/82H3N2 virus (2.5 LD50) in the presence of a low dose of DK119 (108 CFU ...
Dae-Won Moon (467122), Ji-Hun Jang (467125), Hye Suk Hwang (467119), Sung-Moon Hong (467118), Yu-Na Lee (467124), Min-Kyung Park (329008), Min-Chul Kim (329007), Young-Tae Lee (467116), Young-Man Kwon (467115), Sang-Moo Kang (329015), Young-Hee Cho (233668), Eun-Ji Jeong (467123), Joon-Suk Oh (467126), Sieun Yoo (467117), Yu-Jin Jung (467121), Vu NGO (467114), Eun-Ju Ko (467120), Cheol-Hyun Kim (467127)   +17 more
core   +1 more source

Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015.

, 2018
BackgroundMany serologic studies were done during and after the 2009 influenza pandemic, to estimate the cumulative incidence of influenza A(H1N1)pdm09 virus infections, but there are few comparative estimates of the incidence of influenza A(H3N2) virus ...
Jessica Y. T. Wong, Ranawaka A. P. M. Perera, Fang, Vicky J., Wong, Jessica Y. T., Barr, Ian G, Fang, Vicky J, Wei, Vivian W I, Cowling, Benjamin J., Ranawaka A P M Perera, Vivian W I Wei, Cowling, Benjamin J, J S Malik Peiris, Perera, Ranawaka A P M, Peiris, J. S. Malik, Vivian W. I. Wei, Wong, Jessica Y T, Jessica Y T Wong, Benjamin J. Cowling, Riley, Steven, Kin On Kwok, Kwok, Kin O, J. S. Malik Peiris, Vicky J Fang, Ian G Barr, Wei, Vivian W. I., Steven Riley, Perera, Ranawaka A. P. M., Kwok, Kin On, Benjamin J Cowling, Vicky J. Fang, Barr, Ian G., Ian G. Barr   +31 more
core   +1 more source

Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023

Virology Journal
Background Non-pharmaceutical interventions implemented during the COVID-19 pandemic resulted in a marked reduction in influenza infections globally. The absence of influenza has raised concerns of waning immunity, and potentially more severe influenza ...
Even Fossum, Andreas Rohringer, Torstein Aune, Kjersti Margrethe Rydland, Karoline Bragstad, Olav Hungnes   +5 more
doaj   +1 more source